Compound ID | 161

Update compound information

IMT504

Class: Immunomodulator

Spectrum of activity: Gram-negative
Details of activity: Pseudomonas aeruginosa bacteremia and sepsis
Combined with other compounds: Yes
Institute where first reported: Mid-Atlantic BioTherapeutics, USA
Year first mentioned: 2005
Highest developmental phase: Preclinical
Development status: Active
External links:
Citations:
  • http://aac.asm.org/content/59/2/1225.full
  • http://mid-atlanticbio.com/research/
  • https://bibliotecadigital.exactas.uba.ar/download/paper/paper_00257680_v66_n1_p9_Rodrigues.pdf
  • https://journals.aai.org/jimmunol/article/171/7/3697/71534/Strong-Cytosine-Guanosine-Independent

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.